A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The study is a Phase II, multi center, randomized, double-blind, placebo-controlled study in
male and female subjects, aged ≥ 19 years with skin pruritus. All subjects will receive BID
topical applications of PAC-14028 cream or vehicle for up to 4 weeks.